Acumen Pharmaceuticals Statistics
NASDAQ: ABOSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.1865-0.0068 (-3.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Acumen Pharmaceuticals by the numbers
Acumen Pharmaceuticals has a market capitalization of $13.5 million based on 72.33M shares outstanding. With trailing EPS of $-1.55, Acumen Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 88.1% below its 50-day average and 92.1% below its 200-day average.
Average daily trading volume is 2.73M shares, or about $508,653 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABOS valuation vs. peer median
| Metric | ABOS | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.49M | $12.03M | +12% |
| Avg. volume | 2.73M | 167.87K | +1525% |
Peer median across 8 companies: PLUR, ESLA, PASG, BSEM, BCDA, DYAI, TCRX, ATYR.
Valuation
- Market cap
- $13.49M
- EPS (TTM)
- $-1.55
- Shares outstanding
- 72.33M
Price and trading
- Previous close
- 0.1933
- Open
- 0.1861
- Day range
- 0.1601 – 0.1927
- 52-week range
- 0.16 – 3.60
- 52-week change
- -88.12%
- Beta
- —
- Volume
- 2.71M
- Average volume
- 2.73M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 26, 2026
Additional statistics
- Market Cap
- 13.49M
- Forward Pe
- -0.38
- Eps
- -1.55
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.60
- Week52 Low
- 0.16
- Avg Volume
- 2.73M
- Shares Outstanding
- 72.33M
- Ma50
- 1.57
- Ma200
- 2.35
- Earnings Date
- Oct 26, 2026
- Pct From52w High
- -94.82%
- Pct From52w Low
- 16.56%